Senior Manager, Predictive Customer Engagement

Princeton, New Jersey, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must possess a Bachelor's degree in a quantitative field, with a preference for an MBA or other graduate degree. A minimum of 3 years of experience is required, along with proficiency in Python/R and SQL. Experience with designing and deploying machine learning models using Scikit-Learn, Tensorflow, or Pytorch, along with familiarity with Git, cloud-based environments (AWS, Azure), and MLOps, is essential.

Responsibilities

The Senior Manager, Predictive Customer Engagement will develop and deliver analytical assessments, solution designs, and modeling capabilities to enhance US customer experience and engagement across the portfolio. Key duties include ideating, designing, developing, modeling, and deploying advanced solutions using machine learning to predict next best actions. The role involves building and owning predictive machine learning solutions, translating complex models into business language, partnering with the broader Data Science & AI Predictive Solutions organization, and monitoring the external analytics landscape to apply new capabilities.

Skills

Data Science

Machine Learning

Predictive Modeling

Customer Engagement

Analytics

Commercialization Strategy

Data Analysis

Solution Design

Deployment

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free